| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CFO, Cbo | President, CFO, Cbo & Sec'y +3 more
1 company
Benjamin L Palleiko is Chief Executive Officer at KALV. From September 2018 to April 2026, the filings on record show 0 open-market purchases and 31 sales. Benjamin L Palleiko's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $12.5M at current prices.
Our model assigns Benjamin L Palleiko a below-average insider score of 46/100, based on 27 past trades. Over a 12-month horizon, 15.8% of those trades were profitable, with an average 12-month return of -34.7%.
The KALV filings lean toward selling, a net 330,210 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 22, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Cbo, CFO and Secretary | Sale+OE | 3,073 | $25.70 | $78,976.41 | -8.6% |